Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies

BioSeeker Group AB
March 19, 2013
5072 Pages - SKU: BIOS5014693
Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018
8/4/2014 | published by: MarketsandMarkets
Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018 Over the years, the western blotting market, comprising of instruments and consumables,  |  read more...
USD 4,650
Monoclonal Antibodies Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
Monoclonal Antibodies Partnering Terms and Agreements The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee  |  read more...
USD 2,995
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
8/4/2014 | published by: Roots Analysis
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 EXAMPLE HIGHLIGHTS 1. Driven by the sales of Adcetris and Kadcyla (the two drugs currently available commercially), the ADC market is likely to be  |  read more...
USD 1,899
Antibodies in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
Antibodies in Oncology: Drug Pathway Analyzer 2014 Extra value: One year of free online updates included with this product There are today at least 608 antibody drugs known to affect more than 206 specific intracellular signaling pathways  |  read more...
USD 6,746
Antibody Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
Antibody Deals and Alliances of 2013 The Antibody Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.  |  read more...
USD 1,495
Cancer Monoclonal Antibody Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
Cancer Monoclonal Antibody Partnering Terms and Agreements The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading  |  read more...
USD 1,995
Antibodies in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Antibodies in Oncology Drug Pipeline Update 2014 The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the  |  read more...
USD 6,746
Cancer Vaccines Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Cancer Vaccines Drug Pipeline Update 2014 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has proved elusive, leaving  |  read more...
USD 6,746
Single-use Bioreactors Market, 2014-2024
4/23/2014 | published by: Roots Analysis
Single-use Bioreactors Market, 2014-2024 There is widespread optimism that the single-use bioreactors market is likely to continue its double digit growth in the future. The concept of “single-use technology”, which started in 1970s with  |  read more...
USD 1,899
Drug Delivery Technologies Market Forecast 2014-2024
4/30/2014 | published by: Visiongain
Drug Delivery Technologies Market Forecast 2014-2024 Drug Delivery Technologies - new study showing you trends, R&D progress, and predicted revenues Where is the drug delivery technologies market heading? What are the commercial prospects  |  read more...
USD 3,004
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 5,175  
    Global Site License Fulfilled by Publisher  USD 12,937.50  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!